You are here

  • Home
  • Archive
  • Volume 6, Issue 9
  • Multicentre, prospective, randomised, open-label, blinded end point trial of the efficacy of allopurinol therapy in improving cardiovascular outcomes in patients with ischaemic heart disease: protocol of the ALL-HEART study

Citation Tools

Article menu

Download PDFPDF

XML
Cardiovascular medicine
Protocol
Multicentre, prospective, randomised, open-label, blinded end point trial of the efficacy of allopurinol therapy in improving cardiovascular outcomes in patients with ischaemic heart disease: protocol of the ALL-HEART study

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Mackenzie IS, Ford I, Walker A on behalf of the ALL-HEART study group, et al
Multicentre, prospective, randomised, open-label, blinded end point trial of the efficacy of allopurinol therapy in improving cardiovascular outcomes in patients with ischaemic heart disease: protocol of the ALL-HEART study
BMJ Open 2016;6:e013774. doi: 10.1136/bmjopen-2016-013774